STAT+: After two deaths in autoimmune cell therapy trial, Artiva is shutting down
According to STAT, Artiva is shutting down after two deaths occurred in a cell therapy trial for autoimmune disease. The report notes the recent deaths are setbacks for drug companies' interest in applying cancer therapy strategies to autoimmune diseases.
AI summary · generated only from source feed metadata; consult originalSource published
Published here
views5
Original source
STAT — Biotech
Media report · consult original reporting
Read the original ↗https://www.statnews.com/2026/10/27/autoimmune-cell-therapy-trial-artiva-therapeutics-shutting-down/Original headline
STAT+: After two deaths in autoimmune cell therapy trial, Artiva is shutting down
AI bilingual edit · consult originalHeadlines are indexed or machine translated, not independent verification of scientific results. Medical news is not clinical advice. Distinguish interstellar concepts from demonstrated space technology using the original source.